Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist
May 30
Saudi Arabian (Tadawul) Healthcare Sector Analysis
UpdatedMay 30, 2024
DataAggregated Company Financials
Companies23
- 7D-5.3%
- 3M-14.2%
- 1Y5.9%
- YTD-2.5%
Over the last 7 days, the Healthcare industry has dropped 6.2%, driven by Dr. Sulaiman Al Habib Medical Services Group declining 4.6%. This takes the industry's 12 month performance to a gain of 4.6%. Earnings are forecast to grow by 16% annually.
Sector Valuation and Performance
Has the Saudi Arabian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 May 2024 | ر.س194.0b | ر.س31.7b | ر.س4.4b | 31.9x | 43.9x | 6.1x |
| Sat, 27 Apr 2024 | ر.س213.1b | ر.س30.5b | ر.س4.3b | 35.8x | 49.5x | 7x |
| Mon, 25 Mar 2024 | ر.س217.5b | ر.س30.3b | ر.س4.2b | 35.7x | 51.7x | 7.2x |
| Wed, 21 Feb 2024 | ر.س223.1b | ر.س29.2b | ر.س3.9b | 37.8x | 56.7x | 7.6x |
| Fri, 19 Jan 2024 | ر.س192.9b | ر.س29.2b | ر.س3.9b | 34.1x | 49x | 6.6x |
| Sun, 17 Dec 2023 | ر.س189.2b | ر.س29.2b | ر.س3.9b | 32x | 48.1x | 6.5x |
| Tue, 14 Nov 2023 | ر.س179.0b | ر.س29.1b | ر.س4.0b | 32.4x | 44.9x | 6.1x |
| Thu, 12 Oct 2023 | ر.س160.4b | ر.س27.7b | ر.س3.6b | 33.2x | 44.6x | 5.8x |
| Sat, 09 Sep 2023 | ر.س172.2b | ر.س27.5b | ر.س3.6b | 34x | 48.1x | 6.3x |
| Mon, 07 Aug 2023 | ر.س196.5b | ر.س26.0b | ر.س3.4b | 40.3x | 58.4x | 7.5x |
| Wed, 05 Jul 2023 | ر.س202.9b | ر.س26.2b | ر.س3.3b | 41.6x | 61.2x | 7.7x |
| Fri, 02 Jun 2023 | ر.س169.8b | ر.س25.2b | ر.س3.2b | 36.9x | 53x | 6.7x |
| Sun, 30 Apr 2023 | ر.س171.2b | ر.س24.3b | ر.س3.0b | 37.9x | 57.3x | 7x |
| Tue, 28 Mar 2023 | ر.س157.8b | ر.س23.8b | ر.س3.2b | 33.9x | 49.7x | 6.6x |
| Thu, 23 Feb 2023 | ر.س137.6b | ر.س23.2b | ر.س2.9b | 36.6x | 46.7x | 5.9x |
| Sat, 21 Jan 2023 | ر.س135.8b | ر.س23.2b | ر.س2.9b | 36.5x | 46.1x | 5.8x |
| Mon, 19 Dec 2022 | ر.س135.5b | ر.س23.2b | ر.س2.9b | 34.8x | 46x | 5.8x |
| Wed, 16 Nov 2022 | ر.س128.8b | ر.س23.2b | ر.س2.9b | 28.5x | 43.7x | 5.5x |
| Fri, 14 Oct 2022 | ر.س144.1b | ر.س22.8b | ر.س3.0b | 32.9x | 48.8x | 6.3x |
| Sun, 11 Sep 2022 | ر.س125.0b | ر.س22.9b | ر.س3.0b | 28.7x | 42.1x | 5.5x |
| Tue, 09 Aug 2022 | ر.س134.2b | ر.س22.5b | ر.س3.0b | 42.7x | 45.2x | 6x |
| Thu, 07 Jul 2022 | ر.س118.7b | ر.س22.2b | ر.س2.9b | 38.5x | 40.9x | 5.3x |
| Sat, 04 Jun 2022 | ر.س128.5b | ر.س22.2b | ر.س2.9b | 39.5x | 44.3x | 5.8x |
| Mon, 02 May 2022 | ر.س130.1b | ر.س22.0b | ر.س2.8b | 41.9x | 46.2x | 5.9x |
| Wed, 30 Mar 2022 | ر.س121.1b | ر.س21.7b | ر.س2.8b | 39.4x | 43.2x | 5.6x |
| Fri, 25 Feb 2022 | ر.س106.5b | ر.س20.4b | ر.س2.6b | 42.7x | 40.5x | 5.2x |
| Sun, 23 Jan 2022 | ر.س107.5b | ر.س20.2b | ر.س2.6b | 46.7x | 41.9x | 5.3x |
| Tue, 21 Dec 2021 | ر.س100.5b | ر.س20.2b | ر.س2.6b | 45.1x | 39.1x | 5x |
| Thu, 18 Nov 2021 | ر.س102.8b | ر.س20.1b | ر.س2.5b | 43.8x | 40.4x | 5.1x |
| Sat, 16 Oct 2021 | ر.س102.8b | ر.س19.8b | ر.س2.6b | 42.4x | 40.1x | 5.2x |
| Mon, 13 Sep 2021 | ر.س110.9b | ر.س19.8b | ر.س2.6b | 45.8x | 43.3x | 5.6x |
| Wed, 11 Aug 2021 | ر.س119.0b | ر.س19.7b | ر.س2.5b | 43.2x | 46.7x | 6x |
| Sun, 06 Jun 2021 | ر.س102.7b | ر.س18.7b | ر.س2.4b | 41.7x | 43.5x | 5.5x |
Price to Earnings Ratio
43.5x
Current Industry PE
- Investors are relatively neutral on the Saudi Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 46.8x.
- The industry is trading close to its 3-year average PS ratio of 6.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 23% per year over the last three years.
- Revenues for these companies have grown 19% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Saudi Arabian Healthcare sector?
| SA Market | -3.43% | |
| Healthcare | -5.25% | |
| Medical Equipment | 0% | |
| Healthtech | 0% | |
| Biotech | 0% | |
| Life Sciences | 0% | |
| Pharma | -3.90% | |
| Healthcare Services | -5.37% | |
Industry PE
- Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 52.5x.
- Analysts are expecting annual earnings growth of 23.6%, which is lower than the prior year's growth of 28.6% per year.
- Investors are most pessimistic about the Healthcare Services industry, which is trading close to its 3-year average of 45.5x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 24% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 15% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4005 National Medical Care | ر.س181.60 | 4.4% +ر.س340.9m | 64.8% | PE30.6x | |
| 2140 Ayyan Investment | ر.س20.64 | 10.8% +ر.س162.9m | 9.2% | PS4.6x | |
| 9594 Al-Modawat Specialized Medical | ر.س154.00 | 17.6% +ر.س54.6m | n/a | PE20.8x | |
| 9587 Lana Medical | ر.س38.00 | 2.7% +ر.س3.6m | n/a | PE24.9x | |
| 9527 Ame Company For Medical Supplies | ر.س60.00 | 0.8% +ر.س3.5m | 30.7% | n/a |
